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and the early stage of consolidation during trace,
but not delay eyeblink conditioning
Kaori Takehara-Nishiuchi, Shigenori Kawahara,1 and Yutaka Kirino
Laboratory of Neurobiophysics, School of Pharmaceutical Sciences, The University of Tokyo, Bunkyo-ku, Tokyo 113-0033, Japan
Permanent lesions in the medial prefrontal cortex (mPFC) affect acquisition of conditioned responses (CRs) during
trace eyeblink conditioning and retention of remotely acquired CRs. To clarify further roles of the mPFC in this
type of learning, we investigated the participation of the mPFC in mnemonic processes both during and after daily
conditioning using local microinfusion of the GABAA receptor agonist muscimol or the NMDA receptor antagonist
APV into the rat mPFC. Muscimol infusions into the mPFC before daily conditioning significantly retarded CR
acquisition and reduced CR expression if applied after sufficient learning. APV infusion also impaired acquisition of
CRs, but not expression of well-learned CRs. When infusions were made immediately after daily conditioning,
acquisition of the CR was partially impaired in both the muscimol and APV infusion groups. In contrast, rats that
received muscimol infusions 3 h after daily conditioning exhibited improvement in their CR performance
comparable to that of the control group. Both the pre- and post-conditioning infusion of muscimol had no effect on
acquisition in the delay paradigm. These results suggest that the mPFC participates in both acquisition of a CR and
the early stage of consolidation of memory in trace, but not delay eyeblink conditioning by NMDA
receptor-mediated operations.
The prefrontal cortex is implicated in many cognitive functions,
including working memory, the temporal organization of behav-
ior, and emotion (Kolb 1984; Goldman-Rakic 1990; Fuster 1997),
and also is presumed to have the most dynamic and richest in-
teraction with other brain regions (Fuster 2001). Recent reports
have expanded the importance of the rabbit and rodent medial
prefrontal cortex (mPFC) to hippocampus-dependent motor
learning, e.g., trace classical eyeblink conditioning. Since the es-
sential neuronal circuitry for eyeblink conditioning is relatively
well characterized, investigating the role of the mPFC in this task
may contribute to our understanding of the nature of the mPFC’s
interaction with other brain areas.
Trace eyeblink conditioning is a hippocampus-dependent
variation of classical eyeblink conditioning, a process that de-
pends critically on the cerebellum and brainstem (for review, see
Thompson et al. 1997). In this paradigm, the conditioned stimu-
lus (CS) and the unconditioned stimulus (US) are separated by a
stimulus-free trace interval. Previous studies using permanent le-
sion methods have revealed that pre-conditioning lesioning of
the hippocampus (Solomon et al. 1986; Moyer et al. 1990; Mc-
Glinchey-Berroth et al. 1997; Beylin et al. 2001), the medial pre-
frontal cortex (mPFC) (Kronforst-Collins and Disterhoft 1998;
Weible et al. 2000, 2003; McLaughlin et al. 2002), the entorhinal
cortex (Ryou et al. 2001), and the mediodorsal thalamus (Powell
and Churchwell 2002) all impair acquisition of the trace eye-
blink-conditioned response (CR), suggesting that the circuitry for
this learning covers multiple regions of the brain, as others have
previously proposed (Weiss and Disterhoft 1996; Green and
Woodruff-Pak 2000). Furthermore, this circuitry is reorganized
after the CR has been completely acquired. Retention of a re-
cently acquired CR is mediated mainly by the hippocampus (Kim
et al. 1995; Takehara et al. 2002, 2003a) and the cerebellum
(Woodruff-Pak et al. 1985; Takehara et al. 2003a), but only mar-
ginally by the mPFC (Powell et al. 2001; Takehara et al. 2003a).
Retention of a remotely acquired CR is mediated by the mPFC
and the cerebellum (Takehara et al. 2003a).
Although these previous studies using permanent lesion
methods have indicated an involvement of the mPFC in trace
eyeblink conditioning, this method has only limited utility when
we seek a detailed understanding of the participation of the
mPFC, because permanent lesions affect not only acquisition,
but also consolidation and retrieval. Therefore, further studies
that can specify the stage of memory and also elucidate the un-
derlying molecular process are required for a more detailed un-
derstanding of the mPFC’s precise role. Here we investigated the
involvement of the mPFC in mnemonic processes during and
after daily conditioning using microinfusion of the -aminobu-
tyric acid type A (GABAA) receptor agonist muscimol. In addi-
tion, we examined the involvement of N-Methyl-D-aspartate
(NMDA) receptors in this process using microinfusion of the
NMDA receptor antagonist 2-amino-5-phosphonovaleric acid
(APV), because synaptic plasticity in the prelimbic area of the
mPFC depends on NMDA receptors (Hirsch and Crepel 1991; Jay
et al. 1995). A preliminary report of some of these data has been
presented previously in abstract form (Takehara et al. 2003b).
Results
Effect of pre-conditioning infusion into the mPFC
of muscimol or APV on trace CR acquisition
Figure 1 shows the effect on acquisition of microinfusion into the
mPFC of the GABAA receptor agonist muscimol or the NMDA
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receptor antagonist APV before daily trace eyeblink conditioning
with trace intervals of 500 msec. Rats received a microinfusion of
one of the drugs before daily conditioning (PBS: n = 11, Musci-
mol: n = 9, APV: n = 8) The adaptive CR% of the rats receiving
PBS infusion before daily pseudoconditioning is also shown
(Pseudo: n = 6). Phase 1 (sp 1 and sp 2) was designed to examine
the effect of the drug on spontaneous eyeblink frequency by
putting the rats in the conditioning box without the presenta-
tion of the CS and US. In sp 2, rats received a microinfusion of
muscimol, APV, or PBS. Statistical analysis using a one-way
ANOVA on sp 2 revealed a significant group effect (F(2,25) = 5.93,
P < 0.01). Post hoc analysis (Tukey HSD) revealed that the mus-
cimol-infusion group differed significantly from the PBS-infusion
group (P < 0.01), although the APV-infusion group did not, sug-
gesting that inactivation of the mPFC reduces spontaneous eye-
blinking. Phase 2 (sessions 1–10) was designed to examine the
drugs’ effects on CR acquisition. As shown in Figure 1, the mus-
cimol-, the APV-infusion, and the pseudoconditioning groups
exhibited a lower adaptive CR% than the control group. This
was confirmed by a two-way repeated measures ANOVA; there
was a significant interaction between groups and sessions
(F(27,306) = 5.48, P < 0.001) and significant effects of group
(F(3,34) = 19.8, P < 0.001) and of session (F(9,306) = 15.6,
P < 0.001). Furthermore, post hoc analysis (Tukey HSD) revealed
that both the muscimol- and the APV-infusion groups differed
significantly from the PBS-infusion group (both P < 0.01), but
not from the pseudoconditioning group (P > 0.05). The simple
main effects of session were significant in the muscimol-infusion
group (F(9,250) = 3.64, P < 0.05), but not in the APV-infusion
group (F(9,250) = 0.958, P > 0.05). Post hoc analysis (Tukey HSD)
confirmed a significant difference between the adaptive CR% in
session 1 and that in session 10 in the muscimol-infusion group
(P < 0.05), but not in the APV-infusion group (P > 0.05). The in-
fusion effects were fully reversible, since all groups increased
their adaptive CR% and the adaptive CR% of the muscimol- and
APV-infusion groups reached an asymptotic level in a manner
comparable to the control group in Phase 3 (sessions 11–16),
during which both groups received PBS infusions. A two-way
repeated measures ANOVA on sessions 11–16 revealed that there
was no significant interaction between groups and sessions
(F(10,125) = 0.991, P > 0.05), and no significant effects of group
(F(2,25) = 2.09, P > 0.05), but there was a significant effect of ses-
sion (F(5,125) = 5.58, P < 0.001). A two-way repeated measures
ANOVA on sessions 14–16 revealed that there was no significant
interaction between groups and sessions (F(4,50) = 0.808,
P > 0.05), and no significant effects of group (F(2,25) = 0.970,
P > 0.05) or of session (F(2,50) = 1.51, P > 0.05). Finally, in Phase
4 (session 17) we tested the effect of muscimol or APV on the
expression of well-learned CRs. In contrast to the successful ex-
pression of the CR observed in the APV-infusion group, the mus-
cimol-infusion group tended to show fewer adaptive CRs. Al-
though this difference did not reach statistical significance (one-
way ANOVA: F(2,25) = 2.93, P > 0.05), the adaptive CR% in session
17 was noticeably reduced compared with that in session 16 (t-
test, P < 0.05). Similar results were obtained when we analyzed all
of the CRs observed in an entire CS–US interval (data not shown).
To investigate the drug’s effect on the temporal pattern of
the CR between groups, we analyzed the CR onset latency and
peak latency of these animals (all CRs observed in the entire
CS–US interval were included). The CR onset latency of the PBS-,
muscimol-, and APV-infusion groups was 436.7 30.9 msec,
430.4 44.9 msec, and 359.3 38.5 msec, respectively. The CR
peak latency of the PBS-, muscimol-, and APV-infusion groups
was 578.8 18.6 msec, 555.4 26.0 msec, and 546.6 16.9
msec, respectively. There were no differences in the CR onset
latencies or the peak latencies among the groups (one-way
ANOVA, both P > 0.05). These results showed that (1) the mus-
cimol infusions into the mPFC before daily conditioning signifi-
cantly retarded CR acquisition, slightly affected expression of the
pre-acquired CRs, and also affected spontaneous eyeblink fre-
quency, and (2) the APV infusion into the mPFC before daily
conditioning significantly impaired acquisition of the trace CR,
but it had no effect on expression of the pre-acquired CRs or on
spontaneous eyeblink frequency. These impairments were not
attributable to the abnormal timing of the acquired CRs because
neither drug had a significant effect on either the CR onset or
peak latency.
Effect of post-conditioning infusion into the mPFC
of muscimol or APV on trace CR acquisition
In the next experiment, we investigated the drug effects on con-
solidation processes, which are presumed to occur after daily
conditioning. Figure 2 shows the effect on CR acquisition of post-
training infusion of muscimol or APV into the mPFC immedi-
ately after daily conditioning during trace eyeblink conditioning
(PBS: n = 12, Muscimol: n = 7, APV: n = 9). The adaptive CR%
of the rats receiving PBS infusion immediately after daily pseu-
doconditioning is also shown (Pseudo: n = 6). The treatment
schedule is shown above the graph. Following the adaptation
session in Phase 1 (sp 1–sp 2), in Phase 2 (sessions 1–10) the rats
were trained in a trace paradigm with microinfusion of PBS, mus-
cimol, or APV immediately after the daily conditioning. Animals
with muscimol or APV infused into the mPFC exhibited a lower
adaptive CR% than that of the control group. Statistical analysis
using a two-way repeated measures ANOVA revealed that there
was a significant interaction between groups and sessions
(F(27,270) = 2.60, P < 0.001) and significant effects of both group
(F(3,30) = 27.0, P < 0.001) and session (F(9,270) = 13.1, P < 0.001).
Post hoc analysis (Tukey HSD) confirmed that the muscimol- and
Figure 1. Effect on trace CR acquisition of intra-mPFC infusion of mus-
cimol or APV before daily conditioning. Average adaptive CR% in the
PBS-infusion group (PBS: n = 11), muscimol-infusion group (Muscimol:
n = 9), APV-infusion group (APV: n = 8), and the PBS-infusion group with
pseudoconditioning (Pseudo: n = 6). (Sp) Spontaneous eyeblink fre-
quency. Both the muscimol- and APV-infusion groups exhibited severe
impairment in CR acquisition. When switched to PBS-infusion in Phase 3,
both groups acquired the CR at approximately the level of the control
group. Reinfusion of muscimol slightly affected CR expression in Phase 4,
but reinfusion of APV had no effect in Phase 4. Error bar, SEM.
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APV-infusion groups were significantly different from the PBS-
infusion group (both P < 0.001) and the pseudoconditioning
group (both P < 0.01). The simple main effects of session were
significant in both the muscimol-infusion group (F(9,250) = 5.11,
P < 0.05), and in the APV-infusion group (F(9,250) = 3.64,
P < 0.05). Post hoc analysis (Tukey HSD) confirmed that there
was a significant difference between the adaptive CR% in session
1 and that in session 10 in the muscimol- and APV-infusion
groups (both P < 0.05). To examine the residual effect of repeated
treatments with these drugs, all rats received PBS infusions in
Phase 3 (sessions 11–16). As expected, all groups increased their
adaptive CR% and the muscimol- and APV-infusion groups
reached an asymptotic level of learning in a manner comparable
to the control group during this overtraining period. A two-way
repeated measures ANOVA on sessions 11–16 revealed that there
was no significant interaction between groups and sessions
(F(10,125) = 0.912, P > 0.05), but there were significant effects of
group (F(2,25) = 3.81, P < 0.05) and session (F(5,125) = 3.67,
P < 0.01). A two-way repeated measures ANOVA on sessions 14–
16 revealed that there was no significant interaction between
groups and sessions (F(4,50) = 0.719, P > 0.05), and no significant
effect of group (F(2,25) = 3.03, P > 0.05) or of session (F(2,50) = 1.43,
P > 0.05). Finally, the rats again received the muscimol or APV
infusion immediately after their conditioning in session 16 to
examine the drug’s effect the next day on retention of the fully
acquired CR. Both the muscimol- and APV-infusion groups re-
tained their CRs in session 17 as successfully as the PBS-infusion
group did (one-way ANOVA, P > 0.05). Similar results were also
obtained when we analyzed all of the CRs observed in an entire
CS–US interval (data not shown).
We also analyzed the latencies to the onset and to the peak
of the CRs in these animals to quantify the drug effects on the
timing of CRs (all CRs observed in an entire CS–US interval were
included). The CR onset latency of the PBS-, muscimol-, and
APV-infusion groups was 387.8 29.6 msec, 421.9 43.9 msec,
and 418.2 33.5 msec, respectively. The CR peak latency of the
PBS-, muscimol-, and APV-infusion groups was 601.5  18.9
msec, 567.9 29.0 msec, and 571.4 26.9 msec, respectively.
There was no difference in either the onset latency or the peak
latency between groups (one-way ANOVA, both P > 0.05). These
results suggest that the consolidation process that occurs imme-
diately after daily trace eyeblink conditioning was partially dis-
rupted by infusion of the muscimol or APV into the mPFC. In
addition, these manipulations were effective only during the ini-
tial phase of CR acquisition. The impairments are not attribut-
able to the abnormal timing of the acquired CRs, since neither
drug had any significant effect on the CR onset or on peak la-
tency.
Effects on trace CR acquisition of delaying infusion
into the mPFC of muscimol by 3 h
In order to specify the time window for the involvement of the
mPFC in the consolidation process, we investigated the effect of
muscimol infusion 3 h after daily trace conditioning (PBS: n = 7;
Muscimol: n = 9) (Fig. 3). The treatment schedule is shown above
the graph. Following the adaptation session in Phase 1 (sp 1–sp
2), the rats received a PBS or muscimol infusion 3 h after their
daily conditioning. The muscimol-infusion group acquired the
adaptive CR in a manner that was comparable to the control
group. Statistical analysis using a two-way repeated measures
ANOVA revealed that there was no significant interaction be-
tween the groups and sessions (F(9,126) = 0.472, P > 0.05) and no
significant effect of group (F(1,14) = 0.002, P > 0.05), but there
was a significant session effect (F(9,126) = 15.5, P < 0.001). Similar
results were also obtained if we analyzed all of the CRs observed
in an entire CS–US interval (data not shown). In addition,
quantitative analysis of the latencies to the onset and to the
peak of the CRs supported a lack of difference in the temporal
pattern between groups (all CRs observed in the entire CS–
US interval were included). The CR onset latency of the PBS-
and muscimol-infusion groups was 398.0  31.7 msec and
536.3 30.5 msec, respectively. The CR peak latency of the PBS-
and muscimol-infusion groups was 413.4  31.7 msec and
592.7 19.6 msec, respectively. The CR onset latency and the
peak latency of the muscimol-infusion group did not differ sig-
nificantly from those of the control PBS-infusion group (t-test,
Figure 2. Effect on trace CR acquisition of intra-mPFC infusion of mus-
cimol or APV immediately after daily conditioning. The rats received mi-
croinfusions immediately after their daily conditioning. Average adaptive
CR% in the PBS-infusion group (PBS: n = 12), the muscimol-infusion
group (Muscimol: n = 7), the APV-infusion group (APV: n = 9), and the
PBS-infusion group with pseudoconditioning (Pseudo: n = 6). (Sp) Spon-
taneous eyeblink frequency. Both the muscimol- and APV-infusion groups
exhibited severe impairment in acquisition of the CR. Error bar, SEM.
Figure 3. Effect on trace CR acquisition of 3-h delayed intra-mPFC
infusion of muscimol. Average adaptive CR% in the PBS-infusion group
(PBS: n = 7) and the muscimol-infusion group (Muscimol: n = 9). (Sp)
Spontaneous eyeblink frequency. The muscimol-infusion group acquired
the CR in a way comparable to the PBS-infusion group. Error bar, SEM.
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both P > 0.05). These results suggest that muscimol infusion into
the mPFC 3 h after daily conditioning had no effect on trace CR
acquisition. Since these results suggested that the consolidation
processes which occur immediately after training probably end
within 3 h, we did not investigate the effect of APV infusion
beyond 3 h after training.
Effects of pre- and post-conditioning infusions into
the mPFC of muscimol on delay CR acquisition
It is worth asking whether the impairments observed in the trace
500 paradigm can be attributed to the important contribution of
the mPFC to mnemonic processes during and immediately after
daily conditioning in this paradigm or to the general time-
dependent disruptive effects of mPFC inactivation. To this end,
we investigated the effect on CR acquisition of muscimol infu-
sion before or immediately after daily conditioning in the delay
paradigm with an interstimulus interval of 250 msec (delay 250
paradigm), in which permanent lesion of the mPFC has no effect
on CR acquisition (Kronforst-Collins and Disterhoft 1998;
Weible et al. 2000) (Figs. 4, 5). Figure 4 shows the effect on ac-
quisition of pre-conditioning infusion of muscimol into the
mPFC during delay eyeblink conditioning (PBS: n = 6; Muscimol:
n = 7). In Phase 1, the rats that had received a microinfusion of
muscimol showed fewer spontaneous eyeblinks than rats that
had received an infusion of PBS in sp 2 (P < 0.05, paired t-test). In
Phase 2, the muscimol-infusion group acquired the delay CR in a
manner comparable to the control group. Statistical analysis us-
ing a two-way repeated measures ANOVA revealed that there was
no significant interaction between the groups and sessions
(F(6,66) = 0.367, P > 0.05) and no significant effect of group
(F(1,11) = 0.036, P > 0.05), but there was a significant session effect
(F(6,66) = 26.6, P < 0.001). Qualitative analysis of CR onset and
peak latency was conducted. The CR onset latency of the PBS-
and muscimol-infusion groups was 120.4  8.1 msec and
117.6 7.3 msec, respectively. The CR peak latency of the PBS-
and muscimol-infusion groups was 148.5  3.4 msec and
139.6 2.8 msec, respectively. The CR onset latency and the
peak latency of the muscimol-infusion group did not differ sig-
nificantly from the latencies of the control PBS-infusion group
(t-test, both P > 0.05).
Next, we investigated the effect of the post-conditioning
infusion of muscimol on CR acquisition in the delay 250 para-
digm (PBS: n = 7; Muscimol: n = 6) (Fig. 5). Following the adap-
tation session in Phase 1 (sp 1–sp 2), the rats received PBS or
muscimol infusion immediately after their daily conditioning.
The muscimol-infusion group acquired the adaptive CR in a
manner comparable to the control group. Statistical analysis us-
ing a two-way repeated measures ANOVA revealed that there was
no significant interaction between groups and sessions
(F(6,66) = 0.746, P > 0.05) and no significant effect of group
(F(1,11) = 0.003, P > 0.05), but there was a significant session effect
(F(6,66) = 34.0, P < 0.001). In addition, qualitative analysis of CR
onset and peak latency was conducted. The CR onset latency of
the PBS- and muscimol-infusion groups was 121.1 3.2 msec
and 128.4 8.2 msec, respectively. The CR peak latency of the
PBS- and muscimol-infusion groups was 144.1 1.6 msec and
145.9 3.5 msec, respectively. The CR onset latency and the
peak latency of the muscimol-infusion group did not differ sig-
nificantly from the latencies of the control PBS-infusion group
(t-test, both P > 0.05). These results suggest that the muscimol
infusion into the mPFC did not affect mnemonic processes either
during or immediately after daily conditioning in the delay 250
paradigm.
Histology
Figure 6A shows a representative photomicrograph of a brain
section from a rat used in the present experiment. Using Nissl-
stained sections, we required that the cannula placements be
within the appropriate area of the prelimbic cortex and that dam-
age to the tissue be limited to just around the cannula. Of a total
of 122 rats, 12 were rejected by this criterion, leaving 28 rats for
the pre-conditioning groups, 28 rats for the post-conditioning
groups, and 16 rats for the 3-h groups in the trace paradigm, and
in the delay paradigm, leaving 13 rats for the pre-conditioning
groups and 13 rats for the post-conditioning groups. In the pseu-
doconditioning group, there were six rats left in the pre- and
post-conditioning groups. Figure 6B–F depict the cannula tip
Figure 4. Effect on delay CR acquisition of pre-conditioning intra-
mPFC infusion of muscimol. Average adaptive CR% in the PBS-infusion
group (PBS: n = 6) and the muscimol-infusion group (Muscimol: n = 7).
(Sp) Spontaneous eyeblink frequency. The muscimol-infusion group ac-
quired the CR in a way comparable to the PBS-infusion group. Error bar,
SEM.
Figure 5. Effect on delay CR acquisition of immediate post-
conditioning intra-mPFC infusion of muscimol. Average adaptive CR% in
the PBS-infusion group (PBS: n = 7) and the muscimol-infusion group
(Muscimol: n = 6). (Sp) Spontaneous eyeblink frequency. The muscimol-
infusion group acquired the CR in a way comparable to the PBS-infusion
group. Error bar, SEM.
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placements of the rats included in the present study (Trace Para-
digm [B] the pre-conditioning groups, [C] the post-conditioning
groups, [D] the 3-h groups; Delay Paradigm [E] the pre-
conditioning groups, [F] the post-conditioning groups). The can-
nula tip placements in the experimental subjects did not differ
from the placements in the controls. The cannula tip placements
in the pseudoconditioning group did not differ from the place-
ments in the other groups (data not shown).
Correlation of cannula position with drug efficacy
The relationship between drug efficacy and cannula position was
examined by correlating the percent impairment (relative to the
adaptive CR% in the PBS infusion group in session 10 for each
group) with the estimated distance between the targeted position
and the actual position of the guide cannulae using the AP and
DV coordination (the muscimol-infusion group: Fig. 7A; the
APV-infusion group: Fig. 7B in the pre-conditioning treatment;
the muscimol-infusion group: Fig. 7C; and the APV-infusion
group: Fig. 7D in the post-conditioning treatment). There was a
significant correlation between the distance of the actual posi-
tion of the guide cannulae from the targeted position and drug
efficacy in the APV-infusion group in the pre-conditioning treat-
ment (Pearson r = 0.943, P < 0.001; Fig. 7B), although the corre-
lations were not significant in the other three groups (Fig.
7A,C,D). In these three groups, we confirmed the lack of corre-
lation by correlating the percent impairment with the actual AP
or DV coordination of the cannula position (data not shown).
Thus, with increasing distance from the targeted site, APV infu-
sions became less efficacious in the pre-conditioning treatment.
Linear regression analysis revealed that the X intercept of the
regression line was 2.08, indicating that the radius of the area of
drug diffusion was within 2 mm. Therefore, the drug mainly
diffused into the rostral mPFC. In addition, lack of correlation in
the other three groups suggests that the partial acquisition ob-
served in these groups cannot be attributed to insufficient drug
diffusion.
Discussion
In the present study, we investigated the participation of the
mPFC in mnemonic processes during and after daily trace eye-
blink conditioning by using microinfusion of muscimol or APV
in several treatment protocols. We found that reversible inacti-
vation of the mPFC during daily conditioning significantly re-
tarded CR acquisition and reduced CR expression if applied after
sufficient learning in trace eyeblink conditioning. Blockade of
NMDA receptors in the mPFC during the daily conditioning se-
verely impaired trace CR acquisition, although it had little effect
on expression of well-learned CRs. Reversible inactivation and
NMDA receptor blockade also partially blocked CR acquisition
when they were performed immediately after, but not as late as
3 h after daily trace conditioning. Acquisition during the delay
250 paradigm was not impaired by inactivation of the mPFC
either during or immediately after daily conditioning. These re-
sults suggest that the mPFC plays important roles specifically in
acquisition of the CR and in the early stage of consolidation of
trace eyeblink CRs, and that these processes require the integrity
of the NMDA receptor system in the mPFC.
Disterhoft and his collaborators (Weible et al. 2000) have
reported that aspiration of the caudal mPFC centering on the
caudal anterior cingulate cortex (ACC)—but not aspiration of the
rostral mPFC centering on the prelimbic cortex (PrL)—severely
impaired acquisition of the CR during trace, but not delay eye-
blink conditioning in rabbits, confirming their own earlier find-
ing (Kronforst-Collins and Disterhoft 1998). On the other hand,
McLaughlin et al. (2002) reported that electrolytic lesioning of
the rostral mPFC retarded trace CR acquisition, but lesioning of
the caudal mPFC had no significant effect. Similar results have
also been obtained with lesions to the mediodorsal thalamus,
which is reciprocally connected to the mPFC (Powell and
Churchwell 2002). Post-learning lesioning of the mPFC only
slightly affected CR retention if it was performed 1 d after learn-
Figure 7. The correlation between the distance between targeted lo-
cation and actual location of the guide cannula (millimeters) and efficacy
of the drug (percent impairment relative to PBS infusion). (A) The corre-
lation of the muscimol-infusion group, (B) the APV-infusion group in the
pre-conditioning treatment, (C) the muscimol-infusion group, and (D)
the APV-infusion group in the post-conditioning treatment. A significant
correlation was observed only in the APV-infusion group in the pre-
conditioning treatment.
Figure 6. Histological reconstructions of cannula placements. (A) A
representative photomicrograph of a coronal section. Scale bar, 2 mm.
(B–F) Schematic illustration of the location of cannula tips in the mPFC in
rats that received an infusion before daily trace eyeblink conditioning (B),
immediately after trace conditioning (C), 3 h after trace conditioning (D),
before daily delay conditioning (E), or immediately after delay condition-
ing (F). A black dot, red dot, or blue dot represents a placement in a PBS-,
muscimol-, or APV-infusion group, respectively. Numbers to the left in-
dicate stereotaxic coordinates relative to bregma. Reprinted with permis-
sion from Elsevier © 1986, Paxinos and Watson 1986.
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ing (Powell et al. 2001; Takehara et al. 2003a). In the present
study, however, the rats that received infusions of muscimol into
the rostral mPFC exhibited significant impairment in both ac-
quisition and expression of well-learned CRs. It is unlikely that
the impairments observed in the muscimol-infusion group were
produced by mere performance deficits, because muscimol infu-
sion before the daily conditioning had no effect on delay CR
acquisition. Moreover, the adaptive CR% of the muscimol-
infusion group did not show any saving effects after the drug
treatments ceased (see sessions 13–16 in Fig. 2). Therefore, the
impairment observed in the muscimol-infusion group appears to
be attributable to the disruption of mnemonic processes in the
mPFC during daily conditioning. There is a possibility that per-
manent loss of the mPFC may induce compensation, and the role
of the mPFC may be partially substituted for by the remaining
mPFC and/or other brain areas, which might explain why the
impairments produced by the permanent lesions were not as se-
vere as those caused by the reversible inactivation. It is worth
noting that the muscimol-infusion group exhibited some re-
sidual ability to learn (Fig. 2). This result can be interpreted in
one of two ways as follows: (1) muscimol did not sufficiently
diffuse to inactivate the rostral mPFC completely, or (2) some
learning was possible when the rostral mPFC was completely
inactivated. In order to assess drug efficacy, we looked at the
correlation between cannula position and the extent of the learn-
ing impairment (Fig. 7). There was no correlation between can-
nula position and the extent of the impairment in the muscimol-
infusion group (Fig. 7A), although there was a significant corre-
lation in the APV-infusion group (Fig. 7B), whose cannula
distributions were similar to those of the muscimol-infusion
group (Fig. 6B,C). Therefore, the insufficient impairment ob-
served in the muscimol-infusion group most likely suggests that
the mPFC is involved in, but not critical for encoding the CS–US
association and expression of well-learned CRs during trace eye-
blink conditioning. Perhaps the role of the mPFC is modulation
of the mnemonic processes in other brain areas such as the hip-
pocampus and the cerebellum. However, we did not directly
measure the area in which the drug’s concentration was within
the effective concentration range. Therefore, the possibility of
insufficient manipulations of the mPFC cannot be totally ex-
cluded.
Although the animals are trained over several days in trace
eyeblink conditioning, unlike single-trial learning, each daily
conditioning session is thought to initiate a consolidation pro-
cess that builds upon its predecessor. Here we have shown that,
at least in the early stage of learning, activation of the mPFC is
required immediately after training (but not 3 h later). Because
the delayed inactivation of the mPFC had no effect on CR acqui-
sition, the effect of muscimol could not be anterograde on the
subsequent conditioning performed on the next day, rather, the
effects are retrograde, affecting consolidation of the information
acquired on the current day. This time-limited involvement of
the mPFC during the first 3 h of the post-training period is simi-
lar to the time course of consolidation in delay eyeblink condi-
tioning (Hernandez and Powell 1983; Scavio et al. 1992; Attwell
et al. 2002; Cooke et al. 2004). It is worth noting that not only
blockade of NMDA receptors, but also inactivation of the mPFC
immediately after the training had no effect on retention of the
acquired CRs the next day, suggesting that requirement of the
mPFC for post-training processing is limited to that stage when
the memory is beginning to be formed. These results suggest that
post-training processes in the mPFC are necessary for memory
fixation, by which short-term synaptic modifications induced by
the daily conditioning are stabilized and become stable changes
in connectivity between neurons (Eichenbaum 2002) during the
intervals between the daily trace-conditioning sessions. As is evi-
dent in Figure 2, both the muscimol- and APV-infusion groups
exhibited some residual ability to learn. These results suggest two
possibilities as follows: (1) the time course of the drug’s efficacy
was insufficient to block the whole process of consolidation, or
(2) there are other brain areas that participate in the consolida-
tion process.
In accordance with other learning tasks, animals with sys-
temic injection of (+)MK-801 (Thompson and Disterhoft 1997;
Takatsuki et al. 2001), mutant mice lacking the NMDA receptor
subunit 1 (Kishimoto et al. 2001), and those with reduced ex-
pression of 2 subunits (Takehara et al. 2004) all exhibit severe
impairments in acquisition during trace eyeblink conditioning.
In the present trace eyeblink conditioning study, we have shown
that APV infusions into the mPFC severely impaired acquisition
and partially impaired consolidation, but did not impair expres-
sion of well-learned CRs. Our results are consistent with the ear-
lier findings, revealing the involvement of NMDA receptors in
mnemonic processes during and immediately after daily condi-
tioning. The method also has enabled us to identify one of the
sites of action, the mPFC. Therefore, it is possible that NMDA-
dependent synaptic modification (Hirsch and Crepel 1991; Jay et
al. 1995) and/or NMDA-mediated modulation of transmission
(Compte et al. 2000) in the mPFC are important for memory
formation during trace eyeblink conditioning. However, it has
been reported that blockade of NMDA receptors in the mPFC
produces a concurrent increase in dopamine release in this area
(Feenstra et al. 2002), which could cause abnormal neuronal ac-
tivity in the mPFC (Yang and Seamans 1996). Therefore, eleva-
tion of dopamine levels by APV infusion also might explain the
impairment observed in this group.
In trace eyeblink conditioning, the hippocampus is required
for both acquisition (Solomon et al. 1986; Moyer et al. 1990;
Beylin et al. 2001) and retention of a recently acquired memory,
but not of a remotely acquired one (Kim et al. 1995; Takehara et
al. 2002, 2003a). These results suggest that the hippocampus is
important for the early processes of memory (acquisition and
consolidation), but the later processes (storage and retrieval) are
mediated by other brain areas. We have proposed that the mPFC
is one of the critical components for these later processes because
permanent lesions in the mPFC preclude retention of a remotely
acquired memory (Takehara et al. 2003a). Pre-conditioning le-
sions in the mPFC affect CR acquisition (Kronforst-Collins and
Disterhoft 1998; Weible et al. 2000; McLaughlin et al. 2002) and
post-conditioning lesions slightly affect retention of recently ac-
quired CRs (Powell et al. 2001; Takehara et al. 2003a). We have
confirmed the involvement of the mPFC in acquisition, the early
stage of consolidation and expression by using reversible inacti-
vation and NMDA receptor blockade in the present study. There-
fore, the mPFC is involved in acquisition, consolidation, storage,
and retrieval, but its importance is greatest in the late memory
processes, which is the reverse of the pattern seen for the hippo-
campus. There are at least two possible explanations for this
time-dependent change in the mPFC’s importance in mnemonic
processes. One is that the role of the mPFC gradually changes
from a modulator of successful memory formation to a critical
component of permanent memory storage. The other is that the
mPFC plays the same role in several stages of memory, but its
importance changes depending on the time-limited contribution
of the hippocampus. Future studies that record neural activity
from the mPFC during trace eyeblink conditioning will provide
further detail concerning the mPFC’s function in this learning.
In conclusion, the present study suggests that the mPFC is
involved in acquisition of CRs as well as in the early stage of
memory consolidation in trace eyeblink conditioning, and that
this process is NMDA receptor dependent. Given that the brain
circuitry that is involved in trace eyeblink conditioning covers
mPFC and trace eyeblink conditioning
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multiple regions of the brain, it will be interesting to investigate
acquisition and consolidation processes in other important brain
components such as the hippocampus and the cerebellum,
which may be closely correlated with processes in the mPFC.
Such investigations may provide additional insight into the pro-
cess of memory formation from the viewpoint of cooperative
interaction among multiple regions of the brain.
Materials and Methods
Subjects
The subjects were male Wistar rats (Japan SLC), weighing 220–
300 g (9 wk old). The animals were housed in standard plastic
cages in a colony room with a 12-h light/12-h dark cycle and
were provided with water and food ad libitum. All experiments
were performed in accordance with the guidelines established by
the Institutional Animal Investigation Committee at the Univer-
sity of Tokyo and the United States National Institutes of Health
“Guide for the Care and Use of Laboratory Animals.” All efforts
were made to optimize comfort and to minimize the use of ani-
mals.
Implantation of guide cannulae for intracerebral
infusion
Rats were anesthetized with ketamine (87 mg/kg, i.p., Sankyo)
and xylazine (13 mg/kg, i.p., Bayer) and their heads were placed
in stereotaxic frames (Narishige) with the skull surface in the
horizontal plane. After the skull was exposed by incision along
the midline, small holes (1.6-mm diameter) were drilled on each
side of the skull at the following coordinates (in millimeters from
bregma): [anteroposterior (AP) +4.0, mediolateral (ML) +0.7] and
[AP +1.2, ML0.7]. Two single-guide cannulae (26 gauge, Plastic
One) were implanted at an angle of20° through each hole, and
their tips were directed to the following coordinates: [AP +3.0,
ML +0.7, dorsoventral (DV) 2.8 to the skull surface] and [AP
+2.2, ML 0.7, DV 2.8]. Since the tip of the infusion cannula
protruded into the prelimbic area 1 mm from the guide cannula,
the final infusion positions were at the following coordinates:
[AP +2.6, ML0.7, DV3.7]. The guide cannulae were fixed on
the skull with dental cement and small stainless steel screws.
Stainless steel stylets, which extended 1 mm beyond the tip of
the guide cannulae, were placed inside the guide cannulae to
prevent occlusion. Four Teflon-coated stainless steel wires (No.
7910; A-M systems) were soldered to connector pins, which were
implanted subcutaneously in the left upper eyelid. Then these
connector pins were fixed on the skull with dental cement and
stainless steel screws. The animals were injected with gentamycin
sulfate (8 mg/kg, i.p., Schering-Plough) and warmed until they
moved spontaneously.
Intracerebral microinfusion and drugs
Rats were mildly restrained in cotton sacks. The stylet was re-
placed by an infusion cannula (33 gauge), which was connected
to a 1-µL Hamilton microsyringe mounted on a microinfusion
pump (Univentor). The tip of the infusion cannula protruded
into the prelimbic area 1 mm from the guide cannula. The rats
were bilaterally infused (always at a speed of 0.5 µL/min) with
either muscimol HBr (0.5 µg, Sigma-RBI) or D,L-2-amino-5-
phosphonovaleric acid (APV) (5 µg, Sigma-RBI) in 0.5 µL PBS, or
they were infused only with 0.5 µL PBS. These doses were chosen
based on recent studies of the rat neocortex (Mello et al. 2000;
Ferreira et al. 2002). After infusion, the infusion cannula was left
in the brain for 1 min to allow the drug to diffuse from the
cannula tip and then it was replaced by the stylet. Rats received
the microinfusion 10 min before (the pre-conditioning group),
immediately after (the post-conditioning group), or 3 h after (the
3-h group) their daily conditioning. Several studies using similar
intracortical infusion procedures have reported that the drugs’
diffusion was restricted to within a 1-mm radius, and that the
time required to diffuse away from the infusion sites was between
1 and 2 h for muscimol and between 30 min and 1 h for APV
(Martin 1991; Izquierdo et al. 1997; Steele and Morris 1999).
However, the exact drug diffusion into each animal was un-
known, because we did not measure the spread of the drug di-
rectly.
Conditioning apparatus
Four cylindrical Plexiglas containers (15 cm in diameter and 25
cm high) were placed in a sound- and light-attenuating chamber.
One rat was placed in each container. A lightweight cable was
connected to the connector pins secured on the animal’s head.
The CS was a 350-msec tone (5 kHz, 85 dB) with a 5-msec rise and
a 5-msec fall time, which was delivered from a speaker (16.5 cm
in diameter) placed above the containers. The US was a 100-msec
periorbital shock (100 Hz square pulses) delivered through a pair
of electrodes implanted in the left upper eyelid; its intensity was
carefully calibrated to give the minimal current required to elicit
an eyeblink/head-turn response, and adjusted daily for each rat
(0.5–5.0 mA). The current intensity presented during the condi-
tioning was not different between the groups (data not shown).
A stimulus-free trace interval of 500 msec was interposed be-
tween the end of the CS and the US onset in the trace paradigm.
In the delay paradigm, the US terminated simultaneously with
the CS (the interstimulus interval was 250 msec). In the pseudo-
conditioning paradigm, the US was presented with a random
interval between 1 and 19 sec after the CS onset. The CR was
monitored through electromyographic (EMG) activity, recorded
with another pair of implanted electrodes.
Behavioral procedure
No less than 5 d after the surgery, spontaneous eyeblinks were
recorded for two session days in the same way as during the
conditioning session, except that no stimuli were presented. A
daily session consisted of 100 trials grouped into 10 blocks, each
of which included nine CS–US paired trials followed by one CS-
alone trial. Trials were separated by a variable intertrial interval
pseudorandomized between 20 and 40 sec, with a mean of 30 sec.
All experiments were performed during the light phase of the
light/dark cycle.
Histology
At the end of the experiment, each animal was intraperitoneally
injected with an excess amount of sodium pentobarbital (>80
mg/kg, Dainippon Pharmaceutical Co.) and perfused intracardi-
ally with 0.9% saline, followed by phosphate-buffered 10% for-
malin. The brain was removed from the skull and stored in 10%
formalin for a few days. After infiltration with 30% sucrose, it was
frozen, sectioned at 60-µm thickness, and stained with cresyl
violet. The sections were subsequently examined under a light
microscope and the locations of the cannula tips were drawn
onto plates from the stereotaxic atlas of the rat brain (Paxinos
and Watson 1986). The distance between the targeted location
and the actual location of the cannula tips was estimated by
calculating the distance from the AP and DV coordinates.
EMG analysis
The EMG activity was band-pass filtered between 0.15 and 1.0
kHz and fed into a computer with a sampling rate of 10 kHz. The
maximum amplitude of the EMG signals during a time period of
t 1 msec was calculated and designated the EMG amplitude at
t. The mean + SD of the EMG amplitudes during the pre-CS pe-
riod (0–300 msec before CS onset) of 100 trials was defined as the
threshold. After extracting the threshold from the raw EMG am-
plitude data, we calculated four values from this EMG amplitude
data in each trial as follows: (1) a “Pre” value that was calculated
by averaging the EMG amplitude data for 300 msec before the CS
onset; (2) a “Startle” value that was calculated by averaging the
EMG amplitude data for 30 msec after the CS onset; (3) a “CR”
value that was calculated by averaging all of the EMG amplitude
data for all sets of the 100-msec periods of EMG data between 50
msec after the CS onset and the US onset; and (4) an “Adaptive
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CR” value that was calculated by averaging the EMG amplitude
data for the period 0–200 msec before the US onset in the CS–US
paired trials. The time window was extended by a subsequent 100
msec for the CR value and the Adaptive CR value calculations in
the CS-alone trials. If the Pre value exceeded 10% of the thresh-
old, the trial was regarded as a hyperactivity trial and excluded
from any further analysis. A trial was assumed to contain a CR or
an adaptive CR if the CR value or the Adaptive CR value exceeded
10% of the threshold, respectively. The ratio of the number of
trials containing the CR or the adaptive CR to the total number
of trials (excluding the hyperactivity trials) was calculated and
denoted the CR% or the adaptive CR%, respectively. The fre-
quencies of the CRs (CR%) and the adaptive CRs (adaptive CR%)
were expressed as a percentage for each session.
To show the temporal pattern of the CR, the trace of the
average EMG amplitude was made as follows: The EMG ampli-
tude data for each rat were averaged over the total number of
trials (excluding the hyperactivity trials) for each day. These trial-
averaged EMG amplitude data were normalized to the time-
averaged values for 300 msec before the CS onset. Since the data
were calculated from the total trials (excluding the hyperactivity
trials), the temporal pattern of the normalized EMG amplitude
data did not depend on the criterion used for detecting the CR.
Furthermore, the latencies of the CR peak and CR onset were
measured for a quantitative analysis of the temporal pattern of
the CR. The CR peak latency was defined as the time interval
from the CS onset to the peak of the EMG amplitude, and the CR
onset latency was defined as the time interval from the CS onset
to the time when the averaged EMG amplitude first met the
criterion for a CR. These values were averaged over those trials in
each session that were judged to contain a CR.
Statistical analysis
All data were expressed as the mean  SEM. Statistical signifi-
cance was determined by a two-way ANOVA with repeated mea-
sures, by a one-way ANOVA, or by a t-test using SPSS statistical
software.
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